These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons. Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603 [TBL] [Abstract][Full Text] [Related]
5. Monomethylfumarate induces γ-globin expression and fetal hemoglobin production in cultured human retinal pigment epithelial (RPE) and erythroid cells, and in intact retina. Promsote W; Makala L; Li B; Smith SB; Singh N; Ganapathy V; Pace BS; Martin PM Invest Ophthalmol Vis Sci; 2014 May; 55(8):5382-93. PubMed ID: 24825111 [TBL] [Abstract][Full Text] [Related]
6. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells. Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740 [TBL] [Abstract][Full Text] [Related]
7. Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway. Macari ER; Lowrey CH Blood; 2011 Jun; 117(22):5987-97. PubMed ID: 21464371 [TBL] [Abstract][Full Text] [Related]
10. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction. Khan F; Ali H; Musharraf SG Exp Cell Res; 2020 Sep; 394(2):112168. PubMed ID: 32653411 [TBL] [Abstract][Full Text] [Related]
11. Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin. Pestina TI; Hargrove PW; Jay D; Gray JT; Boyd KM; Persons DA Mol Ther; 2009 Feb; 17(2):245-52. PubMed ID: 19050697 [TBL] [Abstract][Full Text] [Related]
12. Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data. Rivers A; Jagadeeswaran R; Lavelle D Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R840-R847. PubMed ID: 30067082 [TBL] [Abstract][Full Text] [Related]
13. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model. Rivers A; Vaitkus K; Ruiz MA; Ibanez V; Jagadeeswaran R; Kouznetsova T; DeSimone J; Lavelle D Exp Hematol; 2015 Jul; 43(7):546-53.e1-3. PubMed ID: 25931013 [TBL] [Abstract][Full Text] [Related]
14. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders. Ali H; Khan F; Musharraf SG Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256 [TBL] [Abstract][Full Text] [Related]
15. Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers. Breda L; Motta I; Lourenco S; Gemmo C; Deng W; Rupon JW; Abdulmalik OY; Manwani D; Blobel GA; Rivella S Blood; 2016 Aug; 128(8):1139-43. PubMed ID: 27405777 [TBL] [Abstract][Full Text] [Related]
16. Dietary supplementation with sulforaphane attenuates liver damage and heme overload in a sickle cell disease murine model. Panda H; Keleku-Lukwete N; Kuga A; Fuke N; Suganuma H; Suzuki M; Yamamoto M Exp Hematol; 2019 Sep; 77():51-60.e1. PubMed ID: 31404577 [TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness. Zhu X; Hu T; Ho MH; Wang Y; Yu M; Patel N; Pi W; Choi JH; Xu H; Ganapathy V; Kutlar F; Kutlar A; Tuan D Haematologica; 2017 Dec; 102(12):1995-2004. PubMed ID: 28971909 [TBL] [Abstract][Full Text] [Related]
19. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes. Campbell AD; Cui S; Shi L; Urbonya R; Mathias A; Bradley K; Bonsu KO; Douglas RR; Halford B; Schmidt L; Harro D; Giacherio D; Tanimoto K; Tanabe O; Engel JD Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18808-13. PubMed ID: 22042865 [TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway. Pullarkat V; Meng Z; Tahara SM; Johnson CS; Kalra VK Hemoglobin; 2014; 38(3):188-95. PubMed ID: 24670032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]